European Market Report for Central Venous Catheters 2017 - MedCore

  • ID: 3960404
  • Report
  • Region: Europe
  • 159 pages
  • iData Research
1 of 5

FEATURED COMPANIES

  • 3DT Holdings LLC
  • Bionic
  • Edwards Lifesciences
  • LPI
  • Perouse Medical
  • Smiths Medical
  • MORE
The European CVC market includes acute and chronic CVCs. Acute CVCs are classified as either conventional acute CVCs or antimicrobial acute CVCs. The acute CVC market includes conventional and antimicrobial acute CVCs. The acute CVC market is expected to grow only slightly over the forecast period, driven primarily by increases in the size and age of the European patient pool and the continued reliance on CVCs. The acute CVC market is growing mainly due to the increasing use of antimicrobial CVCs for high-risk patients. These devices sell at a slight premium to conventional devices and the conversion to antimicrobial CVCs will lead to a growth in market value. The introduction of antithrombogenic CVCs has had a positive effect on the market.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • 3DT Holdings LLC
  • Bionic
  • Edwards Lifesciences
  • LPI
  • Perouse Medical
  • Smiths Medical
  • MORE
Table Of Contents I
List Of Figures Xvii
List Of Charts Xxiii
Executive Summary
European Market For Vascular Access Devices And Accessories Overview
Competitive Analysis
Market Trends
Market Developments
Procedure Numbers
Markets Included
Key Report Updates
Version History
Research Methodology
1.1 Research Scope
1.2 9-Step Methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems And Perform Secondary Research
Step 3: Preparation For Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast And Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review And Market Release
Step 9: Customer Feedback And Market Monitoring
Disease Overview
2.1 Basic Anatomy
2.1.1 Human Vascular System
2.2 Vascular Pathology And Disorders
2.2.1 Cancer
2.2.2 End-Stage Renal Disease
2.2.3 Diabetes
Product Assessment
3.1 Product Portfolios
3.1.1 Central Venous Catheters
3.1.1.1 Introduction
3.1.1.1.1 Cvc Procedures
3.1.1.1.2 Cvc Kits
3.1.1.1.3 Cvc Market Segments
3.1.1.2 Angiodynamics
3.1.1.2.1 Neostar™
3.1.1.3 Centurion Medical Products
3.1.1.3.1 Vantex™
3.1.1.3.2 Multi-Med™
3.1.1.3.3 Ava™
3.1.1.4 Cook Medical
3.1.1.4.1 Spectrum®
3.1.1.5 C.R. Bard
3.1.1.5.1 Powerhohn®
3.1.1.5.2 Hohn®
3.1.1.5.3 Other Cvc Offerings
3.1.1.6 Medcomp Inc.
3.1.1.6.1 Pro-Line®
3.1.1.6.2 Vascu-Line®
3.1.1.6.3 Other Cvc Offerings
3.1.1.7 Teleflex Medical
3.1.1.7.1 Standard
3.1.1.7.2 Arrowg+Ard Blue®
3.1.1.7.3 Arrowg+Ard Blue Plus®
3.1.1.7.4 Chlorag+Ard®
3.2 Regulatory Issues And Recalls
3.2.1 November 2015
3.2.2 October 2015
3.2.3 September 2015
3.2.4 August 2015
3.2.5 July 2015
3.2.6 April 2015
3.2.7 March 2015
3.2.8 February 2015
3.2.9 January 2015
3.2.10 December 2014
3.2.11 October 2014
3.2.12 September 2014
3.2.13 May 2014
3.2.14 April 2014
3.2.15 March 2014
3.2.16 January 2014
3.2.17 December 2013
3.2.18 September 2013
3.2.19 August 2013
3.2.20 June 2013
3.2.21 March 2013
3.2.22 February 2013
3.2.23 December 2012
3.2.24 August 2012
3.2.25 June 2012
3.2.26 May 2012
3.2.27 March 2012
3.2.28 February 2012
3.2.29 January 2012
3.3 Clinical Trials
3.3.1 Central Venous Catheters
3.4 Product Pipelines
3.4.1 Alliance Vascular Devices, Llc
3.4.1.1 Freehand Safety Huber Needle®
3.4.2 Angiodynamics
3.4.2.1 Celerity™ Picc Tip Confirmation System With Navigation
3.4.2.2 Firefly
3.4.2.3 Bioflo® Picc Line Extension
3.4.2.4 Bioflo® Port Line Extension
3.4.2.5 Next Generation Bioflo® Picc
3.4.2.6 Next Generation Bioflo® Port
3.4.3 Bluegrass Vascular Technologies, Inc.
3.4.3.1 Surfacer® Inside-Out™ Access System
3.4.4 C.R. Bard
3.4.4.1 Chemical-Resistant Piccs
3.4.4.2 Novel Advanced Material Piccs
3.4.4.3 Powerglide® Pro Midline
3.4.4.4 Accucath®
3.4.4.5 Xenesis™ Acute Hemodialysis Catheter
3.4.4.6 Site~Rite® 8 Ultrasound System
3.4.5 M. C. Johnson
3.4.5.1 Picc Securement Device
3.4.6 Nipro Medical
3.4.6.1 Shielding Safety Needle
3.4.6.2 Safety Syringe
3.4.6.3 Safety Pivc
3.4.7 Parasol Medical
3.4.7.1 Catheter Securement Device
3.4.8 Pavmed Inc.
3.4.8.1 Nextcath™
3.4.9 Phase One Medical
3.4.9.1 Goldilocks™ Long Term Hemodialysis Catheter
3.4.9.2 Triple-Lumen Symetrex™ Hemodialysis Catheter
3.4.10 Prodigy Diabetes Care, Llc.
3.4.10.1 Insulin Pen Needles
3.4.11 Sharklet Technologies, Inc.
3.4.11.1 Sharklet™ Central Venous Catheter
3.4.12 Starboard Medical
3.4.12.1 Catheter Securement Devices
3.4.13 Teleflex Medical
3.4.13.1 Arrow® Endurance™ Extended Dwell Peripheral Catheter System
3.4.13.2 Tip Confirmation For Cvcs, Chronic Hemodialysis Catheters & Ports
3.4.14 Vascular Access Technologies, Inc.
3.4.14.1 Safecvad™
Country Profiles
4.1 Introduction
4.1.1 Population
4.1.2 Gdp Per Capita
4.1.3 Price Index
4.2 Germany
4.3 France
4.4 United Kingdom
4.5 Italy
4.6 Spain
4.7 Benelux
4.8 Scandinavia
4.9 Austria
4.10 Switzerland
4.11 Portugal
Central Venous Catheter Market
5.1 Introduction
5.1.1 Cvc Procedures
5.1.2 Cvc Kits
5.1.3 Cvc Market Segments
5.1.4 Antimicrobial Cvcs
5.1.5 Multi-Lumen Cvcs
5.1.6 Chronic Cvcs
5.2 Unit Analysis
5.2.1.1 Acute Cvc Units Sold By Patient Type
5.3 Market Overview
5.4 Market Analysis And Forecast
5.4.1 Total Central Venous Catheter Market
5.4.2 Total Acute Central Venous Catheter Market
5.4.2.1 Conventional Acute Central Venous Catheter Market
5.4.2.2 Antimicrobial Acute Central Venous Catheter Market
5.4.3 Chronic Central Venous Catheter Market
5.5 Drivers And Limiters
5.5.1 Market Drivers
5.5.2 Market Limiters
5.6 Competitive Market Share Analysis
Abbreviations
Appendix: Company Press Releases
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • 3DT Holdings LLC
  • Bionic
  • Edwards Lifesciences
  • LPI
  • Perouse Medical
  • Smiths Medical
  • MORE
Central venous catheters (CVCs) are used for gaining immediate, high-flow vascular access. CVCs are inserted via the large internal jugular, subclavian and femoral veins. The larger diameter of central veins compared with peripheral veins allows CVCs to have higher potential flow rates and accommodate more lumens. CVCs are commonly used for parenteral nutrition, blood transfusions, blood draws and medication and chemotherapy delivery. CVCs have long been the standard device used for gaining vascular access in emergency situations where patients require large volumes of fluids in short periods of time. CVCs have long been the standard device used to gain vascular access.
Note: Product cover images may vary from those shown
5 of 5
3DT Holdings LLC
3M
Access Scientific
Ambu Inc.
AngioDynamics
Artsana
B. Braun
Baxter International
Becton Dickinson
Bionic
C. R. Bard
Cardinal Health
CareFusion
Codan
Cook Medical
Covidien
Deltamed
Districlass Medical
Edwards Lifesciences
Endeavor Capital
Fresenius
Grupo Sendal
Interrad Medical
Investindustrial
Ivera Medical Corporation
Joline
Kimal
LPI
Medcomp
Medikit
Medtronic
Navilyst Medical
Nipro Medical
Nostix, LLC
Novico
Pentaferte
Perouse Medical
PFM Medical
PFM Medical
PositiveID Corp.
Rays
Romedex
Roundtable Healthcare
Safety Syringes Inc.
Semprus BioSciences
Smiths Medical
SonoSite, Inc.
Teleflex Medical
Terumo
Troge
Vascular Pathways, Inc.
VeriTeQ Acquisition Corp.
VigMed
V-Tech
Vygon
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll